IMCR7:00 AMImmunocore reports second quarter financial results and provides a business updateEnrollment • Phase 3presentation Thu, Aug 6, 2026, 7:00 AM EDTGimmunocore.com
IMCR7:00 AMImmunocore to report second quarter 2026 financial results and host call on August 6, 2026immunocore.com
IMCR8:00 AMImmunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanomaPresentation / Abstract • Phase 1ASCO poster presentation Sun, May 31, 2026, 9:00 AM CDTGimmunocore.com